• Home
  • About PRIOMEDCHILD
    • Aim
    • Background
    • Organisation Structure
    • Advisory Group Members
    • FAQ
  • Partners
    • ANR, France
    • ZonMw, The Netherlands
    • ETF, Estonia
    • AKA, Finland
    • INSERM, France
    • MRCH, Hungary
    • ISS, Italy
    • LAS, Latvia
    • NCBiR, Poland
    • ISCIII, Spain
    • SRC Sweden
    • MRC, UK
    • Germany
  • Workpackages
    • WP 1
    • WP 2
    • WP 3
    • WP 4
    • WP 5
    • WP 6
  • Joint Call
    • Information on granted research projects
    • Call Timeline
    • Countries participating in joint call
    • Call documents
    • National contact persons
    • Interested researchers
  • What's going on
    • Matchmaking Event
    • Events
    • Networks
  • Contact
  • Aim
  • Background
  • Organisation Structure
  • Advisory Group Members
  • FAQ

FAQ

For your information we have gathered and answered the questions PRIOMEDCHILD partners encounter most frequently. To read the answer to each question click on the question itself.

I am a researcher in the field of paediatric medicine development. Can I apply for research funds through the joint/common call of PRIOMEDCHILD?


As a representative from a pharmaceutical company I am seeking contact with a national contact point for paediatric clinical trials. Where can I find such a contact point?

How will more and safer medicines for children become available?


What initiatives are developed to assure the uphold of the Paediatric Regulation?


What is a paediatric investigation plan?


When I look at the EU member states participating as a Partner in PRIOMEDCHILD, I see that my country is not represented. Is it possible to join the PRIOMEDCHILD consortium?


I am aware of the Network of Excellence TEDDY. How do the activities of TEDDY relate to those of PRIOMEDCHILD?